Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Accumulated Expenses (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Accumulated Expenses for 5 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 48.93% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Dec 2025, down 48.93% year-over-year, with the annual reading at $5.4 million for FY2025, 48.93% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $5.4 million at Werewolf Therapeutics, down from $9.0 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $14.2 million in Q4 2022, with the low at $2.9 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $8.9 million, with a median of $8.8 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses soared 307.7% in 2022, then tumbled 53.34% in 2024.
  • Over 5 years, Accumulated Expenses stood at $8.8 million in 2021, then surged by 61.46% to $14.2 million in 2022, then tumbled by 37.39% to $8.9 million in 2023, then grew by 19.5% to $10.6 million in 2024, then crashed by 48.93% to $5.4 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $5.4 million, $9.0 million, and $8.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.